echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Nat Neurosci: Co-morbidity mechanisms associated with C9ORF72 in patients with defrostanda and prefrontal lobe dementia

    Nat Neurosci: Co-morbidity mechanisms associated with C9ORF72 in patients with defrostanda and prefrontal lobe dementia

    • Last Update: 2020-05-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The coding prediction of hexanucleotide amplification of the otoid exchange factor C9ORF72 is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and pre-temporal lobe dementia (FTD)although repeated amplification has been determined to produce toxic products, mRNAs encoded with the C9ORF72 protein will also decrease in affected individualsin the study, researchers tested how C9ORF72 protein levels affect the toxicity of repeated mediaagesIn 66 GGGGCC repeats of C9orf72 in vitro genetically modified mice, one or two endogenous C9ORF72 alleles inactivated induced or accelerated early deathinactivated one or two endogenous C9orf72 alleles in mice expressing 450 repetitive C9orf72 transgenies, exacerbated cognitive impairment, hippocampus neuron allotment, glial activation, and dipeptide regenerative protein accumulationreduced C9ORF72 has been shown to inhibit the rise of repetitive lying autophagythese results support a disease mechanism in ALS/FTD, where C9ORF72 is reduced and can lead to autophagy defects, in synergy with toxic gains from repetitive dependence
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.